Earnings report for Milestone Pharmaceuticals Inc. (MIST) expected on March 19. Analysts predict 16 cents per share on $1.20M revenue. Latest Ratings for MIST Date Firm Action From To Mar 2021 HC Wainwright & Co. Initiates Coverage On Buy Jul 2020 Oppenheimer Upgrades Perform Outperform Jul 2020 Jefferies Upgrades Hold Buy View More Analyst Ratings for MIST View the Latest Analyst Ratings Importance Rank: 1 read more